<DOC>
	<DOCNO>NCT01091298</DOCNO>
	<brief_summary>This Phase I study evaluate safety tolerability tetravalent rota virus vaccine healthy Indian adult male volunteer administer single dose vaccine high possible viral concentration 0.5 mL vaccine .</brief_summary>
	<brief_title>A Study Evaluate Safety Tetravalent Rotavirus Vaccine Healthy Indian Adult Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Indian adult male volunteer . No apparent sign symptom ill health . Properly inform study sign informed consent form ( ICF ) . In case volunteer unable read write , ICF explain presence study independent witness witness sign ICF ; Subject available entire period study reachable study staff postvaccination followup . Known suspected impairment immunological function ; Known hypersensitivity component rotavirus vaccine ; Fever , axillary temperature ≥38.1oC ( ≥100.5oF ) ; measure study staff . History chronic diarrhea ; Clinical evidence active gastrointestinal illness ; Receipt intramuscular ( IM ) , oral , intravenous ( IV ) corticosteroid treatment past 30 day Subjects suspect HIV , hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) positive available clinical history Prior receipt blood transfusion blood product , include immunoglobulin ; Any subject adequately follow safety ; Any condition , opinion investigator , might interfere evaluation study objective . Subject unable maintain diary card</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Safety vaccine</keyword>
</DOC>